Loading cancer entity…
Loading cancer entity…
Clinical trials
21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02625389 | A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures | completed | Phase 4 | 132 | GuerbetINDUSTRY | 1 | Oct 10, 2025 | clinicaltrials |
| NCT04448873 | Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma | completed | Phase 4 | 30 | Children's Hospital of Fudan UniversityOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT04077515 | Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma | completed | Phase 4 | 92 | Children's Hospital of Fudan UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Oct 10, 2025source: clinicaltrials